Subclinical hyperthyroidism

被引:13
作者
Haden, ST [1 ]
Marqusee, E [1 ]
Utiger, RD [1 ]
机构
[1] HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, ENDOCRINE HYPERTENS DIV, BOSTON, MA 02115 USA
关键词
D O I
10.1097/00019616-199607000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subclinical hyperthyroidism is one of several causes of low serum thyroid-stimulating hormone (TSH) concentrations. It is most simply defined as low serum TSH and normal serum thyroid hormone concentrations. Other causes of low serum TSH concentrations from which subclinical hyperthyroidism must be distinguished are nonthyroidal illness and secondary hypothyroidism. The most common cause of subclinical hyperthyroidism is excessive thyroid hormone therapy. Other causes are an autonomously functioning thyroid adenoma, multinodular goiter, and Graves' disease. Because many patients have no evident thyroid disease and because serum TSH concentrations may be normal weeks or more later, intervention should not be seriously considered until the biochemical findings are found to persist. The likelihood of progression to overt hyperthyroidism is low. Some patients have minor symptoms and signs of hyperthyroidism, but most do not, Some may also have minor stimulation of cardiac function, an increased risk of atrial fibrillation, or accelerated bone loss, Management should be based on the cause of the subclinical hyperthyroidism and on whether the patient has any clinical manifestations of thyroid hormone excess or underlying problems likely to be worsened by small increases in thyroid secretion.
引用
收藏
页码:322 / 327
页数:6
相关论文
共 22 条
[1]   THYROID-DYSFUNCTION IN ADULTS OVER AGE 55 YEARS - A STUDY IN AN URBAN UNITED-STATES COMMUNITY [J].
BAGCHI, N ;
BROWN, TR ;
PARISH, RF .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (04) :785-787
[2]   INTERRELATIONSHIPS BETWEEN AGE, THYROID VOLUME, THYROID NODULARITY, AND THYROID-FUNCTION IN PATIENTS WITH SPORADIC NONTOXIC GOITER [J].
BERGHOUT, A ;
WIERSINGA, WM ;
SMITS, NJ ;
TOUBER, JL .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (05) :602-608
[3]   CONTROL OF ADRENERGIC OVERACTIVITY BY BETA-BLOCKADE IMPROVES THE QUALITY-OF-LIFE IN PATIENTS RECEIVING LONG-TERM SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
SABATINI, D ;
AMATO, G ;
CITTADINI, A ;
BELLASTELLA, A ;
LOMBARDI, G ;
SACCA, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1028-1033
[4]   CARDIAC EFFECTS OF LONG-TERM THYROTROPIN-SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
AMATO, G ;
CITTADINI, A ;
LUPOLI, G ;
SACCA, L ;
BELLASTELLA, A ;
LOMBARDI, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :334-338
[5]  
DEWHALLEY P, 1995, BRIT J GEN PRACT, V45, P93
[6]   SCREENING FOR THYROID-DISEASE IN A PRIMARY CARE UNIT WITH A THYROID STIMULATING HORMONE ASSAY WITH A LOW DETECTION LIMIT [J].
EGGERTSEN, R ;
PETERSEN, K ;
LUNDBERG, PA ;
NYSTROM, E ;
LINDSTEDT, G .
BRITISH MEDICAL JOURNAL, 1988, 297 (6663) :1586-1592
[7]   THE NATURAL-HISTORY OF EUTHYROID MULTINODULAR GOITER [J].
ELTE, JWF ;
BUSSEMAKER, JK ;
HAAK, A .
POSTGRADUATE MEDICAL JOURNAL, 1990, 66 (773) :186-190
[8]   CHANGES IN BONE MASS DURING PROLONGED SUBCLINICAL HYPERTHYROIDISM DUE TO L-THYROXINE TREATMENT - A METAANALYSIS [J].
FABER, J ;
GALLOE, AM .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (04) :350-356
[9]   DIASTOLIC DYSFUNCTION IN PATIENTS ON THYROID-STIMULATING HORMONE SUPPRESSIVE THERAPY WITH LEVOTHYROXINE - BENEFICIAL EFFECT OF BETA-BLOCKADE [J].
FAZIO, S ;
BIONDI, B ;
CARELLA, C ;
SABATINI, D ;
CITTADINI, A ;
PANZA, N ;
LOMBARDI, G ;
SACCA, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :2222-2226
[10]   PERSISTENT PROBLEMS WITH THE SPECIFICITY OF IMMUNOMETRIC TSH ASSAYS [J].
LAURBERG, P .
THYROID, 1993, 3 (04) :279-283